4.6 Article

The DEAD-Box RNA Helicase DDX1 Interacts with RelA and Enhances Nuclear Factor kappaB-Mediated Transcription

期刊

JOURNAL OF CELLULAR BIOCHEMISTRY
卷 106, 期 2, 页码 296-305

出版社

WILEY
DOI: 10.1002/jcb.22004

关键词

RNA HELICASE DDX1; NF-kappa B RelA; TRANSCRIPTION; DEAD-BOX; ACTIVATION

资金

  1. MOE [1306018]
  2. [2006CB504300]
  3. [2006AA02Z123]

向作者/读者索取更多资源

DEAD-box RNA helicases constitute the largest family of RNA helicases and are involved in many aspects of RNA metabolism. In this study, we identified RelA (p65), a subunit of nuclear factor-kappaB (NF-kappa B), as a cellular co-factor of DEAD-box RNA helicase DDX1, through mammalian two hybrid system and co-immunoprecipitation assay. Additionally, confocal microscopy and chromatin immunoprecipitation assays confirmed this interaction. In NF-kappa B dependent reporter gene assay, DDX1 acted as a co-activator to enhance NF-kappa B-mediated transcription activation. The functional domains involved were mapped to the carboxy terminal transactivation domain of RelA and the amino terminal ATPase/helicase domain of DDX1. The DDX1 trans-dominant negative mutant lacking ATP-dependent RNA helicase activity lost it transcriptional inducer activity. Moreover, depletion of endogenous DDX1 by specific small interfering RNAs significantly reduced NF-kappa B-dependent transcription. Taken together, the results suggest that DDX1 may play an important role in NF-kappa B-mediated transactivation, and revelation of this regulatory pathway may help to explore the novel mechanisms for regulating NF-kappa B transcriptional activity. J. Cell. Biochem. 106: 296-305, 2009. (C) 2008 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Virology

Emerging coronaviruses: Genome structure, replication, and pathogenesis

Yu Chen, Qianyun Liu, Deyin Guo

JOURNAL OF MEDICAL VIROLOGY (2020)

Letter Medicine, General & Internal

A distinct name is needed for the new coronavirus

Shibo Jiang, Zhengli Shi, Yuelong Shu, Jingdong Song, George F. Gao, Wenjie Tan, Deyin Guo

LANCET (2020)

Article Cell Biology

A novel selective autophagy receptor, CCDC50, delivers K63 polyubiquitination-activated RIG-I/MDA5 for degradation during viral infection

Panpan Hou, Kongxiang Yang, Penghui Jia, Lan Liu, Yuxin Lin, Zibo Li, Jun Li, Shuliang Chen, Shuting Guo, Junyu Wu, Hong Peng, Weijie Zeng, Chunmei Li, Yingfang Liu, Deyin Guo

Summary: CCDC50 is a newly discovered autophagy receptor that negatively regulates the type I interferon signaling pathway by targeting K63-polyubiquitinated RLRs for autophagic degradation, which enhances viral resistance and survival rates in mouse models.

CELL RESEARCH (2021)

Article Virology

Safety and Considerations of the COVID-19 Vaccine Massive Deployment

Junwei Li, Mingyue Song, Deyin Guo, Yongxiang Yi

VIROLOGICA SINICA (2021)

Article Biochemistry & Molecular Biology

CCDC50 suppresses NLRP3 inflammasome activity by mediating autophagic degradation of NLRP3

Yuxin Lin, Zibo Li, Yicheng Wang, Tian Tian, Penghui Jia, Yu Ye, Miao He, Zixiao Yang, Chunmei Li, Deyin Guo, Panpan Hou

Summary: This study identifies a novel autophagy cargo receptor, CCDC50, which negatively regulates NLRP3 inflammasome assembly and the release of related inflammatory factors by degrading NLRP3. CCDC50 deficiency results in upregulation of signaling pathways associated with autoinflammatory diseases and enhances gut inflammation response.

EMBO REPORTS (2022)

Review Virology

Reverse genetics systems for SARS-CoV-2

Wenhao Wang, Xiaoxue Peng, Yunyun Jin, Ji-An Pan, Deyin Guo

Summary: The ongoing COVID-19 pandemic has led to severe public health crises and economic losses. Limited knowledge about the SARS-CoV-2 virus calls for more research. Reverse genetics systems, like viral infectious clones and replicons, provide powerful platforms for various viral research projects. The development of noninfectious replicons allows for safer operations in more widely available Biosafety Level 2 (BSL2) facilities. After the outbreak, multiple reverse genetics systems for SARS-CoV-2 have been developed, offering researchers various options for their studies.

JOURNAL OF MEDICAL VIROLOGY (2022)

Article Oncology

CDK4/6 Inhibition Enhances Oncolytic Virus Efficacy by Potentiating Tumor-Selective Cell Killing and T-cell Activation in Refractory Glioblastoma

Jingshu Xiao, Jiaming Liang, Junjie Fan, Panpan Hou, Xiaodong Li, Haipeng Zhang, Kai Li, Lang Bu, Ping Li, Miao He, Yongheng Zhong, Liping Guo, Penghui Jia, Qiaoqiao Xiao, Junyu Wu, Hong Peng, Chunmei Li, Fan Xing, Deyin Guo

Summary: This study presents a promising strategy for the treatment of aggressive glioblastoma (GBM) by combining CDK4/6 inhibitors with oncolytic viruses (OV). CDK4/6 inhibition enhances the efficacy of OV by promoting autophagic degradation of MAVS, impairing antiviral responses, and amplifying oncolysis. Furthermore, CDK4/6 inhibitors and OV synergistically induce immuno-genic cell death and boost antitumor immunity, inhibiting tumor growth and prolonging survival in GBM models.

CANCER RESEARCH (2022)

Letter Cell Biology

Suppression of USP8 sensitizes cells to ferroptosis via SQSTM1/p62-mediated ferritinophagy

Lihong Liu, Birong Zheng, Manhui Luo, Jie Du, Fang Yang, Chuanxin Huang, Zengyi Ma, Chunmei Li, Deyin Guo, Hong Peng

PROTEIN & CELL (2023)

Article Microbiology

PML Body Component Sp100A Is a Cytosolic Responder to IFN and Activator of Antiviral ISGs

Hongchang Dong, Wencheng Wu, Jingjing Li, Yilei Ma, Xiaomei Deng, Deyin Guo, Pei Xu

Summary: This study provides detailed insights into the signal transduction pathways of PML bodies in response to IFN and virus infection. It reveals the involvement of the constitutive component Sp100A in mediating these processes and highlights the importance of nuclear importation of Sp100A in activating essential antiviral genes.
Letter Biochemistry & Molecular Biology

Distinct and relatively mild clinical characteristics of SARS-CoV-2 BA.5 infections against BA.2

Liping Guo, Xue Liu, Yuchen Gu, Jinyan Jiang, Ziyue Yang, Qiuying Lv, Deyin Guo, Yang Yang, Hongzhou Lu, Jing Yuan

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Letter Biochemistry & Molecular Biology

Preclinical characterization and anti-SARS-CoV-2 efficacy of ATV014: an oral cyclohexanecarboxylate prodrug of 1′-CN-4-aza-7,9-dideazaadenosine C-nucleoside

Qifan Zhou, Sidi Yang, Liu Cao, Yang Yang, Tiefeng Xu, Qishu Chen, Hongzhou Lu, Yingjun Li, Deyin Guo, Xumu Zhang

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Letter Biochemistry & Molecular Biology

Host cyclophilin A facilitates SARS-CoV-2 infection by binding and stabilizing spike on virions

Xiangpeng Sheng, Fang Zhu, Hong Peng, Fan Yang, Yi Yang, Cong Yang, Zhen Wang, Wei Chen, Deyin Guo, Ronggui Hu

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Letter Biochemistry & Molecular Biology

PTEN suppresses tumorigenesis by directly dephosphorylating Akt

Lang Bu, Huan Wang, Ji-an Pan, Lang Chen, Fan Xing, Junyu Wu, Shun Li, Deyin Guo

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Letter Biochemistry & Molecular Biology

Modulating the tumor microenvironment via oncolytic virus and PI3K inhibition synergistically restores immune checkpoint therapy response in PTEN-deficient glioblastoma

Fan Xing, Jingshu Xiao, Junyu Wu, Jiaming Liang, Xiaoyu Lu, Liping Guo, Ping Li, Panpan Hou, Chunmei Li, Deyin Guo

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

暂无数据